Advertisement
Research Article

Content Analysis of Oncology-Related Pharmaceutical Advertising in a Peer-Reviewed Medical Journal

  • Kan Yonemori mail,

    kyonemor@ncc.go.jp

    Affiliation: Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan

    X
  • Akihiro Hirakawa,

    Affiliation: Center for Advanced Medicine and Clinical Research, Nagoya University Graduate School of Medicine, Aichi, Japan

    X
  • Masashi Ando,

    Affiliation: Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan

    X
  • Taizo Hirata,

    Affiliation: Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan

    X
  • Mayu Yunokawa,

    Affiliation: Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan

    X
  • Chikako Shimizu,

    Affiliation: Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan

    X
  • Kenji Tamura,

    Affiliation: Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan

    X
  • Yasuhiro Fujiwara

    Affiliation: Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan

    X
  • Published: August 31, 2012
  • DOI: 10.1371/journal.pone.0044393

Reader Comments (1)

Post a new comment on this article

An interesting benchmark

Posted by Athena1 on 10 Sep 2012 at 09:00 GMT

Although the research was limited to a single oncology journal, I found these results interesting and informative. I would not have guessed that ads calling for clinical trial participation would be the category of ads that is notably rising over time. Does this help us understand the motivations of pharmaceutical companies?

No competing interests declared.